INDUCTION CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH CISPLATINUM (C), 5 FLUORO URACIL (F), BLEOMYCIN (B) OR C+

被引：0
|
作者：
BASSOT, F
BRASNU, D
STGUILLY, L
MENARD, M
FABRE, A
DONNADIEU, S
LACCOURREYE, H
JACQUILLAT, C
机构：
[1] HOP SALPETRIERE,DEPT ONCOL,F-75651 PARIS 13,FRANCE
[2] HOP LAENNEC,DEPT HEAD & NECK SURG,F-75340 PARIS 07,FRANCE
来源：
CANCER DRUG DELIVERY | 1986年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] RANDOMIZED COMPARISON OF 2 INDUCTION CHEMOTHERAPY REGIMENS FOR LOCALLY ADVANCED HEAD AND NECK-CANCER
    VOKES, EE
    MORAN, WJ
    WEICHSELBAUM, RR
    TYBOR, AG
    GOLDMAN, ME
    KOZLOFF, M
    SWARTZ, C
    SCHER, N
    AWAN, AM
    PANJE, WR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 208 - 208
  • [42] MULTIDRUG CHEMOTHERAPY USING BLEOMYCIN, METHOTREXATE, AND CISPLATIN COMBINED WITH RADICAL RADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    ZIDAN, J
    KUTEN, A
    COHEN, Y
    ROBINSON, E
    CANCER, 1987, 59 (01) : 24 - 26
  • [43] INTENSIVE INDUCTION CHEMOTHERAPY (IND CT) FOR LOCALLY ADVANCED HEAD AND NECK-CANCER (HNC)
    VOKES, EE
    MORAN, WJ
    LESTER, EP
    SCHILSKY, RL
    BITRAN, JD
    SUTTON, HH
    HAGLE, ME
    SOLARSKI, AM
    KNAPP, BA
    WEICHSELBAUM, RR
    PANJE, WR
    CANCER DRUG DELIVERY, 1986, 3 (01): : 60 - 60
  • [44] INDUCTION CHEMOTHERAPY IN ADVANCED HEAD AND NECK-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED STUDY
    BRUNIN, F
    RODRIGUEZ, J
    JAULERRY, C
    JOUVE, M
    PONTVERT, D
    POINT, D
    MOSSERI, V
    POUILLART, P
    ASSELAIN, B
    BRUGERE, J
    BATAINI, JP
    ACTA ONCOLOGICA, 1989, 28 (01) : 61 - 65
  • [45] MULTIDRUG CHEMOTHERAPY USING BLEOMYCIN, METHOTREXATE, AND CISPLATIN ALONE OR COMBINED WITH RADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    KUTEN, A
    ZIDAN, J
    COHEN, Y
    ROBINSON, E
    CANCER TREATMENT REPORTS, 1983, 67 (06): : 573 - 574
  • [46] BLEOMYCIN AND CIS-PLATINUM WITH OR WITHOUT MITOMYCIN-C IN 110 PREVIOUSLY UNTREATED PATIENTS WITH HEAD AND NECK-CANCER
    ISRAEL, L
    AGUILERA, J
    SOUDANT, J
    PENOT, JC
    BREAU, JL
    MORERE, JF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (03): : 305 - 311
  • [47] Observance and results of concurrent chemoradiotherapy after induction chemotherapy by docetaxel, cisplatin and 5-fluoro-uracil for locally advanced head and neck cancers
    Calderon, B.
    Guerder, C.
    Resbeut, M.
    Fakhry, N.
    Dupuis, C.
    Cowen, D.
    CANCER RADIOTHERAPIE, 2016, 20 (02): : 83 - 90
  • [48] AN INTENSIVE, 5 COURSE, ALTERNATING COMBINATION CHEMOTHERAPY INDUCTION REGIMEN USED IN PATIENTS WITH ADVANCED, UNRESECTABLE HEAD AND NECK-CANCER
    ENSLEY, J
    KISH, J
    TAPAZOGLOU, E
    JACOBS, J
    WEAVER, A
    ATKINSON, D
    AHMED, K
    MATHOG, R
    ALSARRAF, M
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1147 - 1153
  • [49] INDUCTION CHEMOTHERAPY WITH CISPLATIN AND CONTINUOUS INFUSION 5-FLUOROURACIL IN LOCALLY FAR-ADVANCED HEAD AND NECK-CANCER
    VERWEIJ, J
    DEJONG, PC
    DEMULDER, PHM
    VANDERBROEK, P
    ALEXIEVAFIGUSCH, J
    VANPUTTEN, WLJ
    SCHORNAGEL, JH
    RAVASZ, LA
    SNOW, GB
    VERMORKEN, JB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (05): : 420 - 424
  • [50] MODIFIED 5-FLUOROURACIL (5FU)+ CISPLATINUM (CP) REGIMEN IN ADVANCED SQUAMOUS HEAD AND NECK-CANCER (HNC)
    KRASNOW, SH
    WADLEIGH, RG
    ANDERSON, AJ
    WHITE, KS
    COHEN, MH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 216 - 216
12345